<DOC>
	<DOCNO>NCT01629160</DOCNO>
	<brief_summary>The purpose study evaluate feasibility use new technology characterize ventricular wall motion patient indicate map ablation procedure . Echo perform preoperatively patient receive 1-month followup telephone call .</brief_summary>
	<brief_title>Ventricular Wall Motion Characterization</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Be sinus rhythm Have ability provide inform consent study participation willing able comply Clinical Investigational Plan describe evaluation Be undergo map ablation require left heart access either ventricular tachycardia ( VT ) atrial fibrillation ( AF ) accord HRS ( Heart Rhythm Society ) /ESC ( European Society Cardiology ) /German National guideline . The patient need least one follow indication leave heart mapping ablation include study : ) Symptomatic sustain monomorphic VT ( SMVT ) , b ) Frequent PVCs , nonsustained VT , VT presume cause ventricular dysfunction , c ) Bundle branch reentrant interfascicular VTs , ) Symptomatic AF indication ablation per current HRS/ESC/German National guideline patient either 1 ) refractory intolerant least one Class 1 Class 3 antiarrhythmic medication , 2 ) unable/unwilling take antiarrhythmic drug therapy choose ablation first line therapy Have permanent AF Exhibit CheyneStokes respiration Have recent myocardial infarction within 40 day prior enrollment Have undergone cardiac surgery coronary revascularization procedure within 3 month prior enrollment schedule procedure Have recent CVA TIA within 3 month prior enrollment Be le 18 year age Be pregnant Be currently participate clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>